The independent source for health policy research, polling, and news.
181 - 200 of 407 Results
Illegal supplies of fentanyl are being cut with xylazine, a powerful horse tranquilizer. Overdoses involving this veterinary sedative are growing nationally and now Florida officials are tracking the deaths.
The state’s surgeon general grants parents permission to send unvaccinated children to school during a measles outbreak, risking their health and that of others.
While many Republican state lawmakers remain firmly against Medicaid expansion, some key leaders in holdout states are showing a willingness to reconsider. Public opinion, financial incentives, and widening health care needs make resistance harder.
After the U.S. Supreme Court ended the federal right to an abortion and many states banned the procedure, reproductive health care organizations hired dozens of people to help patients arrange travel and pay for care.
Ketamine, approved by the FDA as an anesthetic in 1970, is emerging as a major alternative mental health treatment, and there are now more than 500 ketamine clinics around the country. But with little regulation and widely varying treatment protocols, it’s a medical "wild West."
As national prescription drug distributors and pharmacies restricted the flow of oxycodone and other painkillers in response to the growing opioid crisis, Florida’s most popular grocery store ramped up its sales and distribution of the highly addictive drugs, according to a Tampa Bay Times analysis of federal data.
Health policy during Donald Trump’s tenure was dominated by covid-19 and a failed effort to repeal and replace the Affordable Care Act. His appointments to the Supreme Court led to the end of national abortion rights, and he took steps to increase hospital price transparency and improve care for veterans.
Alex Azar advanced Canadian drug importation as Donald Trump’s secretary of Health and Human Services. Now he chairs the board of a company managing Florida’s importation program.
Adults who develop one autoimmune form of diabetes are often misdiagnosed with Type 2 diabetes. Those wrong diagnoses make it harder to get the appropriate medications and technology to manage their blood sugar. Many Black patients wonder if their race plays a role.
Even in states where laws protect minors’ access to gender-affirming care, malpractice insurance premiums are keeping small and independent clinics from treating patients.
It's been more than a year since the FDA declared a national shortage of Adderall, and it’s affecting more than just patients with ADHD. Those with narcolepsy, a much rarer condition, are often treated with the same medication. Without it, they're often unable to drive or function as usual.
Mental health courts have been touted as a means to help reduce the flow of people with mental illness into jails and prisons. But the specialized diversion programs can struggle to live up to that promise, and some say they’re a bad investment.
Delaying cancer treatment can be deadly — which makes the roadblock-riddled process that health insurers use to approve or deny care particularly daunting for oncology patients.
Thousands of medical devices are sold, and even implanted, with no safety tests.
The Social Security Administration is reclaiming billions of dollars in alleged overpayments from some of the nation's poorest and most vulnerable, leaving some people homeless or struggling to stay in housing, beneficiaries and advocates say.
Thousands of people shared their experiences and related to the financial drain on families portrayed in the “Dying Broke” series, a joint project by KFF Health News and The New York Times that examined the costs of long-term care.
A majority of medical schools now offer dual MD-MBA programs, compared with just a quarter two decades ago. The number of medical students seeking a business degree has nearly tripled. This begs the question: Whom will these doctors serve more, patients or shareholders?
Obamacare had its moment, but not until the faceoff’s final minutes. Front-runner Donald Trump again was not on the debate stage, leaving the other Republican presidential hopefuls to slug it out to break through and gain voters’ attention.
The FDA and the manufacturer were alerted to Profemur titanium hips breaking inside U.S. patients as of 2005. It took 15 years to recall the devices. Many fractures could have been avoided.
© 2026 KFF